The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis
- 1 April 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (7) , 3452-3457
- https://doi.org/10.1182/blood-2007-08-108571
Abstract
Ultralarge von Willebrand factor (UL-VWF) multimers are thought to play a central role in pathogenesis of the disease thrombotic thrombocytopenic purpura (TTP); however, experimental evidence in support of this hypothesis has been difficult to establish. Therefore, to examine directly the requirement for VWF in TTP pathogenesis, we generated ADAMTS13-deficient mice on a TTP-susceptible genetic background that were also either haploinsufficient (Vwf+/−) or completely deficient (Vwf−/−) in VWF. Absence of VWF resulted in complete protection from shigatoxin (Stx)–induced thrombocytopenia, demonstrating an absolute requirement for VWF in this model (Stx has been shown previously to trigger TTP in ADAMTS13-deficient mice). We next investigated the requirements for ADAMTS13 and VWF in a murine model of endotoxemia. Unlike Stx-induced TTP findings, LPS-induced thrombocytopenia and mortality were not affected by either VWF or ADAMTS13 deficiency, suggesting divergent mechanisms of thrombocytopenia between these 2 disorders. Finally, we show that VWF deficiency abrogates the ADAMTS13-deficient prothrombotic state, suggesting VWF as the only relevant ADAMTS13 substrate under these conditions. Together, these findings shed new light on the potential roles played by ADAMTS13 and VWF in TTP, endotoxemia, and normal hemostasis.Keywords
This publication has 33 references indexed in Scilit:
- Thrombotic Thrombocytopenic Purpura in Humans and MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veinsBlood, 2006
- Systemic antithrombotic effects of ADAMTS13The Journal of Experimental Medicine, 2006
- ADAMTS13 turns 3Blood, 2005
- Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemiaBlood, 2003
- Searching for a Valid Animal Model of Hemolytic Uremic SyndromeAmerican Journal of Clinical Pathology, 2002
- Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezersBlood, 2002
- Inducible secretion of large, biologically potent von Willebrand factor multimersCell, 1986
- Biosynthesis of von Willebrand protein by human megakaryocytes.Journal of Clinical Investigation, 1985
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1982